In-Hospital Mortality and Costs of Added Morbidity in Heart Failure Patients at a University Hospital: A Retrospective Cross-Sectional Study
In-hospital mortality in HF patients at HUVV is strongly associated with advanced age, disease severity, and multiple comorbidities. Treatment with ACEIs or ARBs was associated with a lower likelihood of in-hospital mortality. Preventable added morbidity was associated with increased healthcare costs, highlighting the importance of infection control measures and multidisciplinary management to potentially improve outcomes and reduce costs.
Authors
- Juan José Gómez‐Doblas (ORCID: https://orcid.org/0000-0002-9020-639X)
- Luís Ortega (ORCID: https://orcid.org/0000-0002-7987-8531)
- Miguel Romero‐Cuevas (ORCID: https://orcid.org/0000-0002-8323-0893)
- Almudena Ortega‐Gómez (ORCID: https://orcid.org/0000-0002-3762-6934)
- Jesús Martínez Tapias
- M. Fernandez (ORCID: https://orcid.org/0009-0006-6156-8582)
- Manuel F. Jiménez‐Navarro (ORCID: https://orcid.org/0000-0002-6759-0514)
Institutions
- Instituto de Salud Carlos III (ES)
- Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (ES)
- Centro de Investigación en Red en Enfermedades Cardiovasculares (ES)
- Centro de Investigación Biomédica en Red (ES)
- Hospital Universitario Virgen de las Nieves (ES)
- Hospital Clínico Universitario Virgen de la Victoria (ES)
- Instituto de Investigación Biomédica de Málaga (ES)
- Universidad de Málaga (ES)
Publication Details
- Journal
- Journal of Cardiovascular Development and Disease
- Published
- 2025-05-15
- DOI
- https://doi.org/10.3390/jcdd12050185
- Citations
- 1
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- European Commission
- Instituto de Salud Carlos III